George Demetri, Director at Blueprint Medicines Corp (BPMC), sold 8,084 shares at $100.88 ($809K) on 2018-03-19, disclosed to the SEC on 2018-03-21.
Open-market sale of $809k BPMC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.06 | 1,200 | $119K | 14.7% |
| 2 | $100.04 | 2,592 | $259K | 32.1% |
| 3 | $100.04 | 2,592 | $259K | 32.1% |
| 4 | $100.88 | 1,700 | $171K | 21.2% |
| Total | $100.07 avg | 8,084 | $809K | 100% |
| Filing → |
| BPMC | SELL | 2021-01-06 | $170K | — | Filing → |
| BPMC | SELL | 2020-09-24 | $145K | — | Filing → |
| BPMC | SELL | 2020-01-14 | $48K | — | Filing → |